These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 31473186)
1. Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease. Leonhard WN; Song X; Kanhai AA; Iliuta IA; Bozovic A; Steinberg GR; Peters DJM; Pei Y EBioMedicine; 2019 Sep; 47():436-445. PubMed ID: 31473186 [TBL] [Abstract][Full Text] [Related]
2. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model. Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449 [TBL] [Abstract][Full Text] [Related]
3. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease. Seo S; Kim H; Hwang JT; Kim JE; Kim J; Jeon S; Song YJ; Choi KH; Sim G; Cho M; Yoon JW; Kim H Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062520 [TBL] [Abstract][Full Text] [Related]
4. Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency. Chang MY; Ma TL; Hung CC; Tian YC; Chen YC; Yang CW; Cheng YC Sci Rep; 2017 Aug; 7(1):7161. PubMed ID: 28769124 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease. Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461 [TBL] [Abstract][Full Text] [Related]
6. A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease. Dagorn PG; Buchholz B; Kraus A; Batchuluun B; Bange H; Blockken L; Steinberg GR; Moller DE; Hallakou-Bozec S Kidney Int; 2023 May; 103(5):917-929. PubMed ID: 36804411 [TBL] [Abstract][Full Text] [Related]
7. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model. Talbi K; Cabrita I; Kraus A; Hofmann S; Skoczynski K; Kunzelmann K; Buchholz B; Schreiber R FASEB J; 2021 Oct; 35(10):e21897. PubMed ID: 34473378 [TBL] [Abstract][Full Text] [Related]
9. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease. Wang W; Geng X; Lei L; Jia Y; Li Y; Zhou H; Verkman AS; Yang B FASEB J; 2019 May; 33(5):6185-6196. PubMed ID: 30768374 [TBL] [Abstract][Full Text] [Related]
10. Metformin induces lactate accumulation and accelerates renal cyst progression in Pkd1-deficient mice. Chang MY; Tsai CY; Chou LF; Hsu SH; Yang HY; Hung CC; Tian YC; Ong ACM; Yang CW Hum Mol Genet; 2022 May; 31(10):1560-1573. PubMed ID: 34957500 [TBL] [Abstract][Full Text] [Related]
11. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease. Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472 [TBL] [Abstract][Full Text] [Related]
12. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD. Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569 [TBL] [Abstract][Full Text] [Related]
13. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease. Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257 [TBL] [Abstract][Full Text] [Related]
14. Effect of celastrol on the progression of polycystic kidney disease in a Pkd1-deficient mouse model. Chang MY; Hsieh CY; Lin CY; Chen TD; Yang HY; Chen KH; Hsu HH; Tian YC; Chen YC; Hung CC; Yang CW Life Sci; 2018 Nov; 212():70-79. PubMed ID: 30268856 [TBL] [Abstract][Full Text] [Related]
15. Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease. Sato Y; Qiu J; Hirose T; Miura T; Sato Y; Kohzuki M; Ito O Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G464-G473. PubMed ID: 33439105 [TBL] [Abstract][Full Text] [Related]
17. Effects of Suramin on Polycystic Kidney Disease in a Mouse Model of Polycystin-1 Deficiency. Chang MY; Hsu SH; Ma LY; Chou LF; Hung CC; Tian YC; Yang CW Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955634 [TBL] [Abstract][Full Text] [Related]
18. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model. Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca Yanda MK; Liu Q; Cebotaru V; Guggino WB; Cebotaru L J Biol Chem; 2017 Oct; 292(43):17897-17908. PubMed ID: 28887310 [TBL] [Abstract][Full Text] [Related]
20. Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype. Wilson L; Pollard AE; Penfold L; Muckett PJ; Whilding C; Bohlooly-Y M; Wilson P; Carling D Clin Sci (Lond); 2021 Oct; 135(20):2393-2408. PubMed ID: 34622923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]